Medplus Health Services Limited (MEDPLUS) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medplus Health Services Limited (MEDPLUS) has a cash flow conversion efficiency ratio of 0.170x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.13 Billion ≈ $33.89 Million USD) by net assets (Rs18.44 Billion ≈ $199.46 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medplus Health Services Limited balance sheet quality to measure how much of total assets are equity-financed.
Medplus Health Services Limited - Cash Flow Conversion Efficiency Trend (2019–2026)
This chart illustrates how Medplus Health Services Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Medplus Health Services Limited to evaluate the quality of earnings relative to operating cash generation.
Medplus Health Services Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medplus Health Services Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sinosteel Anhui Tianyuan Technology Co Ltd
SHE:002057
|
0.015x |
|
Apollo Commercial Real Estate Finance Inc
NYSE:ARI
|
0.007x |
|
Sihui Fuji Electronics Technology Co Ltd
SHE:300852
|
0.026x |
|
Avino Silver & Gold Mines Ltd
TO:ASM
|
0.043x |
|
FPT Digital Retail JSC
VN:FRT
|
-0.473x |
|
Thinking Electronic Industrial Co Ltd
TW:2428
|
0.046x |
|
Tronox Holdings PLC
NYSE:TROX
|
0.084x |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
0.016x |
Annual Cash Flow Conversion Efficiency for Medplus Health Services Limited (2019–2026)
The table below shows the annual cash flow conversion efficiency of Medplus Health Services Limited from 2019 to 2026. For the full company profile with market capitalisation and key ratios, see MEDPLUS company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs19.75 Billion ≈ $213.55 Million |
Rs5.27 Billion ≈ $56.99 Million |
0.267x | -16.25% |
| 2025-03-31 | Rs17.40 Billion ≈ $188.16 Million |
Rs5.54 Billion ≈ $59.96 Million |
0.319x | +249.68% |
| 2024-03-31 | Rs15.77 Billion ≈ $170.59 Million |
Rs1.44 Billion ≈ $15.54 Million |
0.091x | +50.23% |
| 2023-03-31 | Rs14.91 Billion ≈ $161.19 Million |
Rs904.10 Million ≈ $9.78 Million |
0.061x | -49.40% |
| 2022-03-31 | Rs14.17 Billion ≈ $153.27 Million |
Rs1.70 Billion ≈ $18.37 Million |
0.120x | +2931.44% |
| 2021-03-31 | Rs7.31 Billion ≈ $79.07 Million |
Rs28.91 Million ≈ $312.65K |
0.004x | +131.75% |
| 2020-03-31 | Rs5.29 Billion ≈ $57.22 Million |
Rs-65.89 Million ≈ $-712.58K |
-0.012x | -102.47% |
| 2019-03-31 | Rs2.91 Billion ≈ $31.51 Million |
Rs1.47 Billion ≈ $15.86 Million |
0.503x | -- |
About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soap… Read more